IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 352 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sicart Associates LLC | 389,022 | $19,724,000 | 14.11% |
| BB BIOTECH AG | 7,861,934 | $398,600,000 | 11.03% |
| TANAKA CAPITAL MANAGEMENT INC | 62,101 | $3,149,000 | 7.02% |
| DOWLING & YAHNKE LLC | 675,891 | $34,268,000 | 3.48% |
| Asymmetry Capital Management, L.P. | 55,965 | $2,837,000 | 3.29% |
| Motley Fool Asset Management LLC | 259,000 | $13,131,000 | 2.63% |
| AXON CAPITAL LP | 49,500 | $2,510,000 | 2.09% |
| Opus Point Partners Management, LLC | 44,183 | $2,240,000 | 2.01% |
| Motley Fool Wealth Management, LLC | 332,007 | $16,833,000 | 1.43% |
| Bellevue Group AG | 265,706 | $13,469,000 | 1.41% |